{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:08:32Z","timestamp":1768716512082,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:00:00Z","timestamp":1402444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00415-014-7391-y","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T15:27:36Z","timestamp":1406388456000},"page":"501-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review"],"prefix":"10.1007","volume":"262","author":[{"given":"Gaetano","family":"Zaccara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Giovannelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Cincotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Loiacono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Verrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"7391_CR1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2165\/00023210-200519110-00001","volume":"19","author":"E Perucca","year":"2005","unstructured":"Perucca E, Kwan P (2005) Overtreatment in epilepsy: how it occurs and how it can be avoided. CNS Drugs 19:897\u2013908","journal-title":"CNS Drugs"},{"key":"7391_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.62.1.23","volume":"62","author":"FG Gilliam","year":"2004","unstructured":"Gilliam FG, Fessler AJ, Baker G et al (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62:23\u201327","journal-title":"Neurology"},{"key":"7391_CR3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0920-1211(00)00124-8","volume":"41","author":"E Perucca","year":"2000","unstructured":"Perucca E, Beghi E, Dulac O et al (2000) Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Res 41:107\u2013139","journal-title":"Epilepsy Res"},{"key":"7391_CR4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","volume":"11","author":"P Perucca","year":"2012","unstructured":"Perucca P, Gilliam FG (2012) Adverse effects of antiepileptic drugs. Lancet Neurol 11:792\u2013802","journal-title":"Lancet Neurol"},{"key":"7391_CR5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1528-1157.1998.tb01361.x","volume":"39","author":"GA Baker","year":"1998","unstructured":"Baker GA, Camfield C, Camfield P et al (1998) Commission on outcome measurement in epilepsy, 1994\u20131997: final report. Epilepsia 39:213\u2013231","journal-title":"Epilepsia"},{"key":"7391_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1684\/j.1950-6945.2004.tb00064.x","volume":"6","author":"G Zaccara","year":"2004","unstructured":"Zaccara G, Cincotta M, Borgheresi A, Balestrieri F (2004) Adverse motor effects induced by antiepileptic drugs. Epileptic Disord 6:153\u2013168","journal-title":"Epileptic Disord"},{"key":"7391_CR7","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.2174\/1874306400903010123","volume":"3","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 3:e123\u2013e130","journal-title":"Open Med"},{"key":"7391_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","volume":"9","author":"BC Wallace","year":"2009","unstructured":"Wallace BC, Schmid CH, Lau J et al (2009) Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 9:80","journal-title":"BMC Med Res Methodol"},{"key":"7391_CR9","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomized trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"7391_CR10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yebeh.2009.10.007","volume":"17","author":"AB Guekht","year":"2010","unstructured":"Guekht AB, Korczyn AD, Bondareva IB et al (2010) Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav 17:64\u201369","journal-title":"Epilepsy Behav"},{"key":"7391_CR11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1528-1167.2010.02915.x","volume":"52","author":"S Rheims","year":"2011","unstructured":"Rheims S, Perucca E, Cucherat M et al (2011) Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis. Epilepsia 52:219\u2013233","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"7391_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eplepsyres.2011.06.015","volume":"97","author":"AA Shukralla","year":"2011","unstructured":"Shukralla AA, Tudur-Smith C, Powell GA, Williamson PR, Marson AG (2011) Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms. Epilepsy Res 97(1\u20132):20\u201329","journal-title":"Epilepsy Res"},{"key":"7391_CR13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1756285609337340","volume":"2","author":"M Mula","year":"2009","unstructured":"Mula M, Schmitz B (2009) Depression in epilepsy: mechanisms and therapeutic approach. Ther Adv Neurol Disord 2:337\u2013344","journal-title":"Ther Adv Neurol Disord"},{"key":"7391_CR14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10194-007-0398-3","volume":"8","author":"M Syvertsen","year":"2007","unstructured":"Syvertsen M, Helde G, Stovner LJ et al (2007) Headaches add to the burden of epilepsy. Headache Pain 8:224\u2013230","journal-title":"Headache Pain"},{"key":"7391_CR15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","volume":"51","author":"MP Canevini","year":"2010","unstructured":"Canevini MP, De Sarro G, Galimberti CA et al (2010) Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 51:797\u2013804","journal-title":"Epilepsia"},{"key":"7391_CR16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yebeh.2008.02.006","volume":"13","author":"M Carreno","year":"2008","unstructured":"Carreno M, Gil-Nagel A, Sanchez JC et al (2008) Strategies to detect adverse effects of antiepileptic drugs in clinical practice. Epilepsy Behav 13:178\u2013183","journal-title":"Epilepsy Behav"},{"key":"7391_CR17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.yebeh.2004.01.006","volume":"5","author":"S Pirio Richardson","year":"2004","unstructured":"Pirio Richardson S, Farias ST, Lima AR 3rd et al (2004) Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy. Epilepsy Behav 5:343\u2013347","journal-title":"Epilepsy Behav"},{"key":"7391_CR18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0028-3886.15054","volume":"53","author":"SV Thomas","year":"2005","unstructured":"Thomas SV, Koshy S, Nair CR et al (2005) Frequent seizures and polytherapy can impair quality of life in persons with epilepsy. Neurol India 53:46\u201350","journal-title":"Neurol India"},{"key":"7391_CR19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1528-1157.1997.tb01142.x","volume":"38","author":"CL Deckers","year":"1997","unstructured":"Deckers CL, Hekster YA, Keyser A et al (1997) Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia 38:570\u2013575","journal-title":"Epilepsia"},{"key":"7391_CR20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","volume":"79","author":"JA French","year":"2012","unstructured":"French JA, Krauss GL, Biton V et al (2012) Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 79:589\u2013596","journal-title":"Neurology"},{"key":"7391_CR21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1098\/rstb.2010.0384","volume":"366","author":"P Enck","year":"2011","unstructured":"Enck P, Klosterhalfen S, Weimer K et al (2011) The placebo response in clinical trials: more questions than answers. Philos Trans R Soc 366:1889\u20131895","journal-title":"Philos Trans R Soc"},{"key":"7391_CR22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1352458510370793","volume":"16","author":"D Papadopoulos","year":"2010","unstructured":"Papadopoulos D, Mitsikostas DD (2010) Nocebo effects in multiple sclerosis trials: a meta-analysis. Mult Scler 16:816\u2013828","journal-title":"Mult Scler"},{"key":"7391_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pain.2009.07.010","volume":"146","author":"M Amanzio","year":"2009","unstructured":"Amanzio M, Corazzini LL, Vase L, Benedetti F (2009) A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 146:261\u2013269","journal-title":"Pain"},{"key":"7391_CR24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0333102410391485","volume":"31","author":"DD Mitsikostas","year":"2011","unstructured":"Mitsikostas DD, Mantonakis LI, Chalarakis NG (2011) Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia 31:550\u2013561","journal-title":"Cephalalgia"},{"key":"7391_CR25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00415-011-6197-4","volume":"259","author":"D Papadopoulos","year":"2012","unstructured":"Papadopoulos D, Mitsikostas DD (2012) A meta-analytic approach to estimating nocebo effects in neuropathic pain trials. J Neurol 259:436\u2013447","journal-title":"J Neurol"},{"key":"7391_CR26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1468-1331.2011.03528.x","volume":"19","author":"DD Mitsikostas","year":"2012","unstructured":"Mitsikostas DD, Chalarakis NG, Mantonakis LI, Delicha EM, Sfikakis PP (2012) Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice. Eur J Neurol 19:672\u2013680","journal-title":"Eur J Neurol"},{"key":"7391_CR27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/ene.12014","volume":"20","author":"P Stathis","year":"2013","unstructured":"Stathis P, Smpiliris M, Konitsiotis S, Mitsikostas DD (2013) Nocebo as a potential confounding factor in clinical trials for Parkinson\u2019s disease treatment: a meta-analysis. Eur J Neurol 20:527\u2013533","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-014-7391-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7391-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T13:02:40Z","timestamp":1717160560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-014-7391-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["7391"],"URL":"https:\/\/doi.org\/10.1007\/s00415-014-7391-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}